Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Analyser

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    47 result(s) found for: Analyser. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2006-007035-27 Sponsor Protocol Number: P061005 Start Date*: 2007-09-10
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title: Etude du rapport urinaire des isomères I et III de la coproporphyrine : Relation avec les retards d'élimination du méthotrexate administré à haute dose chez des patients atteints d'une hémopathie l...
    Medical condition: Patients atteints de LMNH ou de LAL, traités par méthotrexate à dose > 1g/m2.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10031593 LMNH ou LAL PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016804-21 Sponsor Protocol Number: FLT-MF-2009 Start Date*: 2010-07-29
    Sponsor Name:Accelerator Advanced Application
    Full Title: Intérêt de la Tomographie par Émission de Positons avec la 3’-désoxy-3’-[18F]-fluoro-thymidine (18F-FLT) pour l’obtention d’une cartographie de l’activité mitotique myéloïde corps entier dans les ...
    Medical condition: démontrer la faisabilité de cette méthode d’imagerie en pathologie médullaire et analyser les paramètres optimaux d’acquisition d’image. caractériser des cartographies médullaires spécifiques, pré-...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004354-90 Sponsor Protocol Number: 270884 Start Date*: 2007-10-03
    Sponsor Name:academisch ziekenhuis Maastricht
    Full Title: Effecten van aspirine op de plaatjesfunctie bij gezonde vrijwillige proefpersonen.
    Medical condition: Aspirin resistance
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-001342-28 Sponsor Protocol Number: PHRC2013-02 Start Date*: 2015-07-23
    Sponsor Name:CHU Angers
    Full Title: TOMOSCINTIGRAPHIE HYBRIDE AUX LEUCOCYTES MARQUES DANS LE DIAGNOSTIC DES INFECTIONS DE PROTHESES VASCULAIRES. Etude LEUCOPRO®
    Medical condition: infection de prothèse vasculaire
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001495-69 Sponsor Protocol Number: 2008/0801 Start Date*: 2008-07-11
    Sponsor Name:Centre Hospitalier Régional et Universitaire de Lille
    Full Title: Réversibilité sous Tiotropium (SPIRIVA®) chez les patients BPCO : paramètres EFR, dyspnée et TDM
    Medical condition: Traitement bronchodilatateur continu destiné à soulager les symptômes des patients présentant une bronchopneumopathie chronique obstructive (BPCO).
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-004917-10 Sponsor Protocol Number: TIGER Start Date*: 2023-06-29
    Sponsor Name:King's College London [...]
    1. King's College London
    2. King's College Hospital NHS Foundation Trust
    Full Title: Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a phase 3, pan-European, two-gro...
    Medical condition: Submacular haemorrhage secondary to exudative age-related macular degeneration
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004853 10075718 Exudative age-related macular degeneration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2004-002243-27 Sponsor Protocol Number: 305/2004 Start Date*: 2004-08-14
    Sponsor Name:Clinical Pharmacology
    Full Title: Vascular effects of peroxisome proliferator–activated receptor gamma stimulation with rosiglitazone during exogenousely elevated free fatty acid concentrations in healthy volunteers
    Medical condition: healthy
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2017-004416-19 Sponsor Protocol Number: PHRC2015-01 Start Date*: 2018-03-16
    Sponsor Name:CHU Angers
    Full Title: Hydroxychloroquine versus placebo : Impact sur les récidives thrombotiques dans le syndrome primaire des antiphospholipides – PAPIRUS
    Medical condition: syndrome primaire des antiphospholipides
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-020219-35 Sponsor Protocol Number: Start Date*: 2011-07-18
    Sponsor Name:Royal Brompton & Harefield NHS Foundation Trust
    Full Title: Evaluating the benefit of additional platelet inhibition in acute coronary syndrome patients with high platelet reactivity undergoing PCI
    Medical condition: Cardiovascular disease - Acute coronary syndrome
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-019837-85 Sponsor Protocol Number: CUTACETUX Start Date*: 2010-05-12
    Sponsor Name:CHU de Poitiers
    Full Title: Étude de la toxicité cutanée du cétuximab (anti-Epidermal Growth Factor Receptor): recherche d’un lien entre la réponse inflammatoire cutanée et la réponse radiologique.
    Medical condition: METASTATIC COLORECTAL CANCER
    Disease: Version SOC Term Classification Code Term Level
    12.1 10052362 Metastatic colorectal cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006842-25 Sponsor Protocol Number: 2008_19\0838 Start Date*: 2009-04-17
    Sponsor Name:CHRU de Lille
    Full Title: Etude monocentrique randomisée en double aveugle versus placebo avec deux groupes parallèles d’efficacité et de tolérance de la défériprone (traitement chélateur de fer) sur la surcharge cérébrale ...
    Medical condition: Maladie de Parkinson
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-000060-34 Sponsor Protocol Number: LOCAL/2015/APM-01 Start Date*: Information not available in EudraCT
    Sponsor Name:CHU de Nîmes
    Full Title: Effets vasculaires et métaboliques d'une supplémentation en Vitamine D associée à une prise en charge hygiéno-diététique chez l'Adolescent Obèse: étude prospective, randomisée, contrôlée
    Medical condition: Obésité chez l'adolescent
    Disease: Version SOC Term Classification Code Term Level
    18.0 10027433 - Metabolism and nutrition disorders 10029883 Obesity PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-000152-14 Sponsor Protocol Number: PHRN/06/LV-RALIB Start Date*: 2007-05-23
    Sponsor Name:CHRU-TOURS
    Full Title: Efficacité de la rapamycine topique dans le traitement des lichens érosifs chroniques de la muqueuse buccale:Etude en double aveugle randomisée rapamycine vs corticoïdes
    Medical condition: Patients atteints de lichen buccal érosif depuis plus de 6 semaines vus en consultation spécialisée dans des hôpitaux universitaires. Comparer l’effet de deux stratégies thérapeutiques, (1) rapamyc...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030983 Oral lichen planus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-003850-26 Sponsor Protocol Number: P070303 Start Date*: 2007-10-31
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title: Etude des effets métaboliques et staturaux de deux modes de traitement par hormone de croissance recombinante des enfants nés petits pour l'âge gestationnel avec déficit statural persistant. Pharma...
    Medical condition: Enfant né Petit pour l'Age Gestionnel traités par rhGH
    Disease: Version SOC Term Classification Code Term Level
    8.1 10053759 Growth retardation PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002048-34 Sponsor Protocol Number: 2016-02 Start Date*: 2018-12-19
    Sponsor Name:Societe Francaise de Cardiologie
    Full Title: Effet pharmacométabolomique des statines : Etude METASTATINE
    Medical condition: patients à haut risque cardio-vasculaire avec dyslipidémie et nécessitant la mise en route d'un traitement par statines et de mesures hygiénodiététiques en prévention primaire
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004849 10042758 Symptoms involving cardiovascular system LLT
    20.0 100000004861 10058110 Dyslipidemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002902-23 Sponsor Protocol Number: PHRC2007-03 Start Date*: 2008-02-11
    Sponsor Name:CHU Angers, directeur général, Yvonnick Morice
    Full Title: EPOMI (ERYTHROPOIETIN IN MYOCARDIAL INFARCTION) : ESSAI RANDOMISE MULTICENTRIQUE EVALUANT L’EFFET D’UNE INJECTION D’ERYTHROPOÏETINE A LA PHASE AIGUË DE L’INFARCTUS DU MYOCARDE SUR LA TAILLE DE LA ...
    Medical condition: Infarctus du myocarde, syndrome coronarien aigu avec susdécalage du segment ST
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004340-67 Sponsor Protocol Number: EG006/208 Start Date*: 2009-04-21
    Sponsor Name:Ark Therapeutics Limited
    Full Title: A multi-centre, double-blind, randomised, placebo-controlled, phase IIa exploratory study of the effects of Imidapril on body weight and body composition in Non-Small Cell Lung Cancer patients with...
    Medical condition: Cancer Cachexia in Non-small Cell Lung Cancer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10064015 Cancer cachexia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DE (Completed) CZ (Completed) HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006695-38 Sponsor Protocol Number: 06 037 03 Start Date*: 2007-02-02
    Sponsor Name:CHU Toulouse
    Full Title: Evaluation pharmacologique des antagonistes du récepteur P2Y12 à l'ADP chez le volontaire sain
    Medical condition: Volontaires sains
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-004136-20 Sponsor Protocol Number: 2008/21 Start Date*: 2008-11-26
    Sponsor Name:CENTRE ANTOINE LACASSAGNE
    Full Title: ETUDE PILOTE DE DEPISTAGE DES SUJETS DEFICITAIRES EN DIHYDROPYRIMIDINE DESHYDROGENASE. APPLICATION AU CANCER DU SEIN TRAITE PAR FLUOROPYRIMIDINE ORALE.
    Medical condition: Cancer du sein métastatique
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-004384-22 Sponsor Protocol Number: 2007-23 Start Date*: 2007-12-05
    Sponsor Name:CENTRE ANTOINE LACASSAGNE
    Full Title: ETUDE DE PHASE II EVALUANT UNE RADIOTHERAPIE - CHIMIOTHERAPIE + CETUXIMAB CHEZ DES PATIENTS PORTEURS D’UN CARCINOME EPIDERMOÏDE DE LA CAVITE BUCCALE, DE L’OROPHARYNX, DE L’HYPOPHARYNX OU DU LARYNX ...
    Medical condition: Patients porteurs d’un carcinome épidermoïde de la cavité buccale, de l’oropharynx, de l’hypopharynx ou du larynx histologiquement prouvé et de mauvais pronostic après chirurgie complète
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 11:54:26 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA